Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teneligliptin vs Sitagliptin in T2DM (TETRIS)
NCT02567994Phase 3Completed
- Sponsor
- Handok
- Start
- Apr 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by Handok. Started Apr 2015; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02567994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02567994.